Dr. Byung-Ho Rhie | Cancer Awards | Kangwon National University | South Korea
Dr. Byung-Ho Rhie is a highly accomplished biomedical researcher and academic with extensive expertise in cancer biology, stem cell research, and targeted therapeutics, with a particular focus on non-small cell lung cancer (NSCLC) drug resistance mechanisms and human pluripotent stem cell biology. He earned his Ph.D. from the College of Science and Technology, Hanyang University, and has held multiple postdoctoral and senior researcher positions at Hanyang University and Kangwon National University, where he contributed to international collaborative research projects and translational biomedical studies. Dr. Byung-Ho Rhie’s professional experience includes establishing NSCLC research platforms, generating osimertinib-resistant EGFR-mutant cell lines, performing CRISPR/Cas9-mediated knockout of drug resistance factors, and investigating novel therapeutic strategies for drug-resistant cancers. His research on pluripotent stem cells includes developing xeno-free and chemically defined culture conditions, identifying and characterizing deubiquitinating enzymes regulating pluripotency factors such as OCT4 and SOX2, and performing genome-wide CRISPR functional screenings. His scholarly output includes five Scopus-indexed publications with 50 citations and an h-index of 4, demonstrating both depth and impact in biomedical research.
Citation Metrics (Scopus)
Citations
Documents
h-index
View Scopus Profile
Featured Publication